Patents by Inventor Guanghui Deng

Guanghui Deng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11934078
    Abstract: A display panel and a display device are disclosed. The display panel includes a photoresist layer, a liquid crystal layer, and a total reflection layer. Liquid crystal molecules included in the liquid crystal cells have a first refractive index and a second refractive index. The first refractive index is greater than the second refractive index, and a refractive index of the total reflection units matches with the first refractive index. The display panel and the display device not only have advantages of low manufacturing cost and eye protection, but can also achieve color and dynamic display.
    Type: Grant
    Filed: May 12, 2021
    Date of Patent: March 19, 2024
    Assignee: WUHAN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD.
    Inventors: Qian Deng, Rui He, Changchih Huang, Guanghui Liu
  • Patent number: 8389508
    Abstract: The present invention relates to novel compounds having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: March 5, 2013
    Assignee: Glaxo Group Limited
    Inventors: Guanghui Deng, Xichen Lin, Feng Ren, Baowei Zhao
  • Publication number: 20120101136
    Abstract: 5-membered heteroaryl derivatives of formula (I) or salts thereof, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptors are disclosed.
    Type: Application
    Filed: June 24, 2010
    Publication date: April 26, 2012
    Inventors: Guanghui Deng, Xichen Lin, Feng Ren, Jia-Ning Xiang
  • Publication number: 20120101134
    Abstract: 5-membered heteroaryl derivatives of formula (I) or salts thereof, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptors are disclosed.
    Type: Application
    Filed: June 24, 2010
    Publication date: April 26, 2012
    Applicant: GLAXO GROUP LIMITED
    Inventors: Guanghui Deng, Xichen Lin, Qinghua Meng, Feng Ren, Jia-Ning Xiang, Heng Xu, Haibo Zhang, Baowei Zhao
  • Publication number: 20110269738
    Abstract: The present invention relates to novel compounds having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
    Type: Application
    Filed: April 28, 2011
    Publication date: November 3, 2011
    Applicant: Glaxo Group Limited
    Inventors: Guanghui Deng, Xichen Lin, Feng Ren, Baowei Zhao